Journal article 821 views 328 downloads
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
Steve Bain ,
Brian B. Hansen,
Samuel J. P. Malkin,
Solomon Nuhoho,
William J. Valentine,
Barrie Chubb,
Barnaby Hunt,
Matthew Capehorn
Diabetes Therapy, Volume: 11, Issue: 1, Pages: 259 - 277
Swansea University Author: Steve Bain
-
PDF | Version of Record
Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (CC-BY-NC).
Download (937.3KB)
DOI (Published version): 10.1007/s13300-019-00736-6
Abstract
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
Published in: | Diabetes Therapy |
---|---|
ISSN: | 1869-6953 1869-6961 |
Published: |
Springer Science and Business Media LLC
2020
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa52765 |
first_indexed |
2019-11-18T13:14:14Z |
---|---|
last_indexed |
2020-10-29T04:06:58Z |
id |
cronfa52765 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2020-10-28T16:59:46.9787878</datestamp><bib-version>v2</bib-version><id>52765</id><entry>2019-11-18</entry><title>Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2019-11-18</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes Therapy</journal><volume>11</volume><journalNumber>1</journalNumber><paginationStart>259</paginationStart><paginationEnd>277</paginationEnd><publisher>Springer Science and Business Media LLC</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1869-6953</issnPrint><issnElectronic>1869-6961</issnElectronic><keywords/><publishedDay>1</publishedDay><publishedMonth>1</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-01-01</publishedDate><doi>10.1007/s13300-019-00736-6</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2020-10-28T16:59:46.9787878</lastEdited><Created>2019-11-18T10:11:37.8872651</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>1</order></author><author><firstname>Brian B.</firstname><surname>Hansen</surname><order>2</order></author><author><firstname>Samuel J. P.</firstname><surname>Malkin</surname><order>3</order></author><author><firstname>Solomon</firstname><surname>Nuhoho</surname><order>4</order></author><author><firstname>William J.</firstname><surname>Valentine</surname><order>5</order></author><author><firstname>Barrie</firstname><surname>Chubb</surname><order>6</order></author><author><firstname>Barnaby</firstname><surname>Hunt</surname><order>7</order></author><author><firstname>Matthew</firstname><surname>Capehorn</surname><order>8</order></author></authors><documents><document><filename>52765__16190__0b8b9377e899452588633880c1b6294a.pdf</filename><originalFilename>52765.pdf</originalFilename><uploaded>2019-12-31T16:18:17.2205082</uploaded><type>Output</type><contentLength>959793</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (CC-BY-NC).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by-nc/4.0/</licence></document></documents><OutputDurs/></rfc1807> |
spelling |
2020-10-28T16:59:46.9787878 v2 52765 2019-11-18 Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2019-11-18 MEDS Journal Article Diabetes Therapy 11 1 259 277 Springer Science and Business Media LLC 1869-6953 1869-6961 1 1 2020 2020-01-01 10.1007/s13300-019-00736-6 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2020-10-28T16:59:46.9787878 2019-11-18T10:11:37.8872651 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Steve Bain 0000-0001-8519-4964 1 Brian B. Hansen 2 Samuel J. P. Malkin 3 Solomon Nuhoho 4 William J. Valentine 5 Barrie Chubb 6 Barnaby Hunt 7 Matthew Capehorn 8 52765__16190__0b8b9377e899452588633880c1b6294a.pdf 52765.pdf 2019-12-31T16:18:17.2205082 Output 959793 application/pdf Version of Record true Released under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (CC-BY-NC). true eng https://creativecommons.org/licenses/by-nc/4.0/ |
title |
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme |
spellingShingle |
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme Steve Bain |
title_short |
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme |
title_full |
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme |
title_fullStr |
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme |
title_full_unstemmed |
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme |
title_sort |
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme |
author_id_str_mv |
5399f4c6e6a70f3608a084ddb938511a |
author_id_fullname_str_mv |
5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain |
author |
Steve Bain |
author2 |
Steve Bain Brian B. Hansen Samuel J. P. Malkin Solomon Nuhoho William J. Valentine Barrie Chubb Barnaby Hunt Matthew Capehorn |
format |
Journal article |
container_title |
Diabetes Therapy |
container_volume |
11 |
container_issue |
1 |
container_start_page |
259 |
publishDate |
2020 |
institution |
Swansea University |
issn |
1869-6953 1869-6961 |
doi_str_mv |
10.1007/s13300-019-00736-6 |
publisher |
Springer Science and Business Media LLC |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
1 |
active_str |
0 |
published_date |
2020-01-01T07:47:15Z |
_version_ |
1821300213415936000 |
score |
11.047393 |